
SYGFOL-DHA Clinical Monograph & Batch COA
Certified DCGI Formulation Literature (PDF)
SYGFOL-DHA
L-Methyl Folate + Pyridroxyl-5-Phosphate + Methylcobalamin & DHA
SYGFOL-DHA is a high-potency antioxidant and cytoprotective nutraceutical engineered to optimize mitochondrial cellular bio-energetics and cardiovascular endurance.
Clinical Pharmacology & Therapeutic Profile
Comprehensive therapeutic guidelines for medical practitioners and institutional procurement
Therapeutic Indications
Mechanism of Action (MOA)
Acts as an essential cofactor in the mitochondrial electron transport chain (ATP synthesis) and scavenges free radicals to prevent lipid peroxidation.
1 unit daily post meals with adequate water, or as recommended by the clinical nutritionist.
Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.
Store below 25°C in a dry place. Protect from moisture and direct sunlight.
WHO-GMP Certified Purity
Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.
Alu-Alu Moisture Barrier
Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.
Exclusive District Monopoly
Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.
Technical Product Specifications
Active Medical Composition
SYGFOL-DHA features L-Methyl Folate + Pyridroxyl-5-Phosphate + Methylcobalamin & DHA prepared to high pharmaceutical purity standards.
*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.
Customer & Clinical Reviews
Real feedback from registered physicians, stockists, PCD franchise partners, and verified buyers.
Based on 1 verified review
Documented with consistent patient for SYGFOL-DHA
SYGFOL-DHA has been documented with consistent patient tolerance in our case records, achieving targeted therapeutic objectives with remarkable tolerability profiles. The blister strips are easy to pop without shattering or edge crumbling of adjacent units. An essential formulation that consistently lives up to its certified pharmacopoeial claims.
Questions Regarding SYGFOL-DHA
What is the therapeutic indication and composition of SYGFOL-DHA?
SYGFOL-DHA contains L-Methyl Folate + Pyridroxyl-5-Phosphate + Methylcobalamin & DHA indicated for Cardiovascular Support as formulated by Sygnus Biotech.
What packaging presentations are available for SYGFOL-DHA?
SYGFOL-DHA is supplied in tamper-evident 10 x 10 Alu-Alu / Blister Pack, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.
Is monopoly PCD franchise territory available for SYGFOL-DHA?
Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for SYGFOL-DHA along with promotional visual aids, product cards, and marketing support.
What is the regulatory schedule and minimum order quantity (MOQ)?
SYGFOL-DHA is categorized as Schedule H with an introductory PCD franchise MOQ of 100 units per batch.





